Abstract:Historically inflammation against self was considered autoimmune which stems back to the seminal observations by Ehrlich who described serum factors, now known to be autoantibodies produced by B lineage cells that mediate "horror autotoxicus". The 20th century elucidation of B- and T-cell adaptive immune responses cemented the understanding of the key role of adaptive immune responses in mediating pathology against self. However, Mechnikov shared the Nobel Prize for the discovery of phagocytosis, the most rudimentary aspect of innate immunity. Fast forward some 100 years and an immunogenetic understanding of innate immunity led to the categorising of innate immunopathology under the umbrella term 'auto inflammation' and terminology such as "horror autoinflammaticus" to highlight the schism from the classical adaptive immune understanding of autoimmunity. These concepts lead to calls for a two-tiered classification of inflammation against self, but just as innate and adaptive immunity are functionally integrated, so is immunopathology in many settings and the concept of an autoimmune to autoinflammation continuum emerged with overlaps between both. Herein we describe several historically designated disorders of adaptive immunity where innate immunity is key, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD) where the immunopathology phenotype is strongly linked to major histocompatibility complex (MHC) class II associations and responds to drugs that target T-cells. We also consider MHC-I-opathies including psoriasis and Behcet's disease(BD) that are increasingly viewed as archetype CD8 T-cell related disorders. We also briefly review the key role of barrier dysfunction in eczema and ulcerative colitis (UC) where innate tissue permeability barrier dysfunction and microbial dysbiosis contributes to prominent adaptive immune pathological mechanisms. We also highlight the emerging roles of intermediate populations of lymphocytes including gamma delta (γδ) and mucosal-associated invariant T (MAIT) cells that represent a blend of adaptive immune plasticity and innate immune rapid responders that may also determine site specific patterns of inflammation.

Sensors of the Innate Immune System: Their Link to Rheumatic Diseases

Intracellular Nucleic Acid Sensors and Autoimmunity.

Role of DNA/RNA sensors and contribution to autoimmunity

Sensors of the innate immune system: their mode of action

Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases.

How underappreciated autoinflammatory (innate immunity) mechanisms dominate disparate autoimmune disorders

Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases

Inflammasomes and human autoimmunity: A comprehensive review

Advances in Disease Mechanisms and Translational Technologies: Clinicopathologic Significance of Inflammasome Activation in Autoimmune Diseases

Stretching the Function of Innate Immune Cells

Environment and systemic autoimmune rheumatic diseases: an overview and future directions

The Role of Toll-Like Receptors in Autoimmune Diseases through Failure of the Self-Recognition Mechanism

Innate Immunity in Host-Microbial Interactions: Beyond B27 in the Spondyloarthropathies

Innate immune processes in lupus erythematosus

Regulation of Adaptive Immunity by the Innate Immune System

Regulation of Inflammation in Autoimmune Disease

Innate Immune Sensing of Microbial Infection: the Mechanism and the Therapeutic Challenge.

Aberrant Activation of Immune and Non-Immune Cells Contributes to Joint Inflammation and Bone Degradation in Rheumatoid Arthritis

Microrna-Mediated Regulation of Innate Immune Response in Rheumatic Diseases

Trained immunity and inflammation in rheumatic diseases

Application and Prospect of Targeting Innate Immune Sensors in the Treatment of Autoimmune Diseases